New York/Paris — Johnson & Johnson’s experimental coronavirus vaccine protected a handful of primates with a single shot in an early study, prompting the US drugmaker to start trials on humans this month.
The data “show our SARS-CoV-2 vaccine candidate generated a strong antibody response and provided protection with a single dose”, Paul Stoffels, the drugmaker’s chief scientific officer, said in the statement. “The findings give us confidence as we progress our vaccine development and upscale manufacturing in parallel.”
J&J, which received a $456m award from the Biomedical Advanced Research and Development Authority, has already entered discussions with the US, the EU, and governments around the world about supplying its vaccine should it prove successful in the clinic.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: TheCitizen_News - 🏆 6. / 75 Read more »
Source: eNCA - 🏆 49. / 51 Read more »
When it comes to Covid-19 vaccines, its every man (or country) for themselfGlobal health agencies are watching with dismay as some wealthier countries have decided to go it alone, striking deals with drugmakers to secure millions of doses of promising Covid-19 vaccine candidates for their citizens.
Source: IOL - 🏆 46. / 51 Read more »
New York-based business lawyer behind moves to gain a controlling share of the StormersThe New York-based man behind moves to gain a controlling share of the Stormers is a high flying business lawyer with a penchant for human rights issues.
Source: SowetanLIVE - 🏆 13. / 63 Read more »
UK signs deal for 60-million Sanofi/GSK vaccine dosesThis is the fourth such deal amid worries that rich countries, such as the US and UK, are securing vaccine doses at the expense of poorer ones
Source: BDliveSA - 🏆 12. / 63 Read more »
Source: TheCitizen_News - 🏆 6. / 75 Read more »